Somophyllin | Benefits, Uses & Side Effects Guide

Introduction to Somophyllin

Somophyllin is a brand name for a medication containing theophylline or aminophylline, which are methylxanthine derivatives obtained from tea. It is a bronchodilator drug primarily used for treating wheezing, shortness of breath, and difficulty breathing associated with conditions like asthma, chronic bronchitis, and emphysema.

Chemical Composition and Derivation

Somophyllin contains either theophylline or aminophylline, which are methyl xanthine derivatives derived from tea. These compounds are chemically related to caffeine and have been used for their bronchodilator effects in respiratory conditions.

Medical Uses and Indications

The primary medical use of Somophyllin is for treating wheezing, shortness of breath, and difficulty breathing caused by conditions such as asthma, chronic bronchitis, and emphysema. It acts as a bronchodilator, relaxing the smooth muscles in the airways and improving airflow.

Formulations of Somophyllin

Somophyllin is available in various formulations, including:

• Somophyllin Oral Solution
• Somophyllin-12 sustained-release capsules
• Somophyllin-T

Dosage and Administration

The dosage of Somophyllin varies depending on the formulation, patient’s age, and severity of the condition. Standard dosages are typically based on body weight and adjusted based on the patient’s response and blood levels. Sustained-release forms like Somophyllin-12 are designed to provide a consistent level of the drug in the body over an extended period. In young asthmatic children, a sprinkle preparation may be used for easier administration.

Mechanism of Action

Somophyllin, containing theophylline or aminophylline, exerts its effects through several mechanisms:

• Bronchodilation: It relaxes the smooth muscles in the airways, leading to bronchodilation and improved airflow.
• Cardiac stimulation: It has positive chronotropic (increased heart rate) and inotropic (increased contractility) effects on the heart.
• Central nervous system stimulant activities: It acts as a mild central nervous system stimulant.
• Mild diuretic effects: It has mild diuretic properties, promoting the excretion of water and electrolytes.

Pharmacokinetics

The pharmacokinetic properties of Somophyllin are influenced by its formulation and individual patient factors:

• Absorption: Theophylline and aminophylline are readily absorbed from the gastrointestinal tract.
• Distribution: These compounds are widely distributed throughout the body and can cross the placenta.
• Metabolism : They are primarily metabolized in the liver by the cytochrome P450 enzyme system.
• Excretion : The metabolites are excreted primarily through the kidneys.

Contraindications

Somophyllin is contraindicated in patients with certain medical conditions, such as:

• Severe cardiac arrhythmias
• Severe coronary artery disease
• Hyperthyroidism
• Peptic ulcer disease
• Seizure disorders

Side Effects and Adverse Reactions

Common side effects of Somophyllin may include:

• Nausea and vomiting
• Headache
• Insomnia
• Restlessness
• Palpitations

Severe side effects that require medical attention include:

• Seizures
• Irregular heartbeat
• Severe allergic reactions

Drug Interactions

Somophyllin may interact with various medications, including:

• Certain antibiotics, antidepressants, and antifungal drugs
• Medications that can affect the metabolism or clearance of theophylline, such as cimetidine and phenytoin
• Medications that can increase the risk of adverse effects, such as beta-blockers and diuretics

Clinical Studies and Evaluation

Several clinical studies have been conducted to evaluate the efficacy and safety of Somophyllin formulations:

• A study on dose requirements and dose intervals for sustained-release theophylline in asthmatic children and adults.
• An evaluation of Somophyllin-12 in young children with asthma, demonstrating its safety and effectiveness.

Withdrawal from the Market

In the 1990s, the manufacturer Fisons withdrew Somophyllin from the market due to various reasons, including the availability of newer and more effective bronchodilator medications. This withdrawal had an impact on patients who had been using Somophyllin for managing their respiratory conditions, and they were required to switch to alternative treatments under medical supervision.